These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 33464914)

  • 21. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
    Karthik K; Senthilkumar TMA; Udhayavel S; Raj GD
    Hum Vaccin Immunother; 2020 Dec; 16(12):3055-3060. PubMed ID: 32845733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
    Khan T; Agnihotri K; Tripathi A; Mukherjee S; Agnihotri N; Gupta G
    Altern Ther Health Med; 2020 Aug; 26(S2):56-64. PubMed ID: 32412918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive overview of COVID-19 based on current evidence.
    Kang Y; Xu S
    Dermatol Ther; 2020 Sep; 33(5):e13525. PubMed ID: 32378801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review.
    Bhat EA; Khan J; Sajjad N; Ali A; Aldakeel FM; Mateen A; Alqahtani MS; Syed R
    Int Immunopharmacol; 2021 Jun; 95():107493. PubMed ID: 33721758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.
    Shahverdi M; Darvish M
    Curr Mol Med; 2021; 21(7):562-572. PubMed ID: 33272178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development.
    Mehmood I; Ijaz M; Ahmad S; Ahmed T; Bari A; Abro A; Allemailem KS; Almatroudi A; Tahir Ul Qamar M
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and hepatitis B infection.
    Alqahtani SA; Buti M
    Antivir Ther; 2020; 25(8):389-397. PubMed ID: 33616549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies.
    Zabidi NZ; Liew HL; Farouk IA; Puniyamurti A; Yip AJW; Wijesinghe VN; Low ZY; Tang JW; Chow VTK; Lal SK
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
    Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of host-to-host transmission by SARS-CoV-2 vaccines.
    Mostaghimi D; Valdez CN; Larson HT; Kalinich CC; Iwasaki A
    Lancet Infect Dis; 2022 Feb; 22(2):e52-e58. PubMed ID: 34534512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convergence between global BCG vaccination and COVID-19 pandemic.
    Islam MZ; Zahan MK; Al-Bari MAA
    J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2.
    Goraichuk IV; Arefiev V; Stegniy BT; Gerilovych AP
    Virus Res; 2021 Sep; 302():198473. PubMed ID: 34118360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
    Bilal M; Iqbal HMN
    Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era.
    Volkan E
    Mol Biotechnol; 2021 Oct; 63(10):885-897. PubMed ID: 34145550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.